We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
-6.99%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$1.71B
AUM Growth
-$39.6M
Cap. Flow
+$72.3M
Cap. Flow %
4.23%
Top 10 Hldgs %
57.63%
Holding
146
New
23
Increased
28
Reduced
39
Closed
16

Top Buys

Rank Stock Value
1
SLNO
Soleno Therapeutics
SLNO
+$28.5M
2
ESTA icon
Establishment Labs
ESTA
+$27.8M
3
PTON icon
Peloton Interactive
PTON
+$16.6M
4
SVRA icon
Savara
SVRA
+$15.3M
5
OPTN
OptiNose
OPTN
+$12.2M

Top Sells

Rank Stock Value
1
CASH icon
Pathward Financial
CASH
+$25.3M
2
LYRA
LYRA THERAPEUTICS INC
LYRA
+$17.5M
3
RDVT icon
Red Violet
RDVT
+$13.4M
4
DYN icon
Dyne Therapeutics
DYN
+$12.4M
5
GDEN
Golden Entertainment
GDEN
+$9.92M

Sector Composition

Rank Sector Weight
1 Healthcare 39.62%
2 Consumer Discretionary 7%
3 Financials 3.63%
4 Communication Services 3.53%
5 Technology 1.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IWM icon
1
PUT
iShares Russell 2000 ETF
IWM
$79.1B
$274M 16.01%
1,350,000
– –
LLY icon
2
PUT
Eli Lilly
LLY
$1.08T
$145M 8.47%
160,000
+60,000
+60% +$48M
SLNO
3
DELISTED
Soleno Therapeutics
SLNO
$126M 7.35%
3,082,107
+671,728
+28% +$28.5M
ESTA icon
4
Establishment Labs
ESTA
$2.71B
$114M 6.67%
2,512,850
+548,288
+28% +$27.8M
XBI icon
5
PUT
State Street SPDR S&P Biotech ETF
XBI
$10B
$111M 6.5%
1,200,000
-700,000
-37% -$62.8M
IWM icon
6
CALL
iShares Russell 2000 ETF
IWM
$79.1B
$60.9M 3.56%
+300,000
New +$60.6M
LOPE icon
7
PUT
Grand Canyon Education
LOPE
$4.22B
$56M 3.27%
400,000
– –
PTON icon
8
Peloton Interactive
PTON
$2.85B
$37M 2.16%
10,935,331
+4,622,392
+73% +$16.6M
EOLS icon
9
Evolus
EOLS
$397M
$31.6M 1.85%
2,910,849
– –
BVS icon
10
Bioventus
BVS
$889M
$30.7M 1.79%
5,338,314
-467,698
-8% -$2.57M
CASH icon
11
Pathward Financial
CASH
$1.88B
$30.6M 1.79%
541,433
-480,294
-47% -$25.3M
IMAX icon
12
IMAX
IMAX
$2.67B
$30.2M 1.76%
1,798,260
-404,917
-18% -$6.7M
HGV icon
13
Hilton Grand Vacations
HGV
$4.04B
$27M 1.58%
668,871
– –
PTON icon
14
CALL
Peloton Interactive
PTON
$2.85B
$27M 1.58%
7,987,000
+5,587,000
+233% +$20M
SVRA icon
15
Savara
SVRA
$1.08B
$20.9M 1.22%
5,180,951
+3,443,541
+198% +$15.3M
CRMT icon
16
America's Car Mart
CRMT
$25.9M
$18.8M 1.1%
312,128
– –
RDNW
17
RideNow Group
RDNW
$256M
$18.1M 1.06%
4,416,506
– –
KROS icon
18
Keros Therapeutics
KROS
$197M
$17.3M 1.01%
378,807
+84,810
+29% +$4.56M
AMRX icon
19
Amneal Pharmaceuticals
AMRX
$6.1B
$17M 0.99%
2,669,943
+50,000
+2% +$317K
IMAX icon
20
CALL
IMAX
IMAX
$2.67B
$16.8M 0.98%
+1,000,000
New +$16.5M
ABEO icon
21
Abeona Therapeutics
ABEO
$355M
$14.7M 0.86%
3,470,037
+1,159,397
+50% +$5.91M
OPTN
22
DELISTED
OptiNose
OPTN
$14.4M 0.84%
894,583
+729,630
+442% +$12.2M
ABVX
23
Abivax
ABVX
$10.4B
$13M 0.76%
985,634
-24,400
-2% -$349K
RZLT icon
24
Rezolute
RZLT
$453M
$12.9M 0.75%
2,989,963
-32,984
-1% -$113K
TBBK icon
25
The Bancorp
TBBK
$2.81B
$12.8M 0.75%
+337,846
New +$11.2M
1
2 3 4 5

Similar funds

TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
FNF
Fidelity National Financial Jacksonville, Florida $2.72B AUM 29.3% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
NB
Nicolet Bankshares Green Bay, Wisconsin $2.71B AUM 17.55% 1-Year Est. Return
MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
BCM
Bowie Capital Management Richardson, Texas $2.71B AUM 5.42% 1-Year Est. Return

Nantahala Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Nantahala Capital Management held 146 positions worth $1.71B, down 2.3% from $1.75B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Nantahala Capital Management deployed $72.3M of net new capital in Q2 2024, opening 23 new positions and adding to 28 existing holdings. Its largest new stake was The Bancorp: 337,846 shares worth $12.8M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 37% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Pathward Financial, an estimated $25.3M trimmed.

  • Nantahala Capital Management's largest Q2 2024 buy was The Bancorp: 337,846 shares worth $12.8M.
  • Nantahala Capital Management added most to Soleno Therapeutics in Q2 2024, an estimated $28.5M increase.
  • Nantahala Capital Management's biggest Q2 2024 reduction was Pathward Financial, cutting an estimated $25.3M.
  • Nantahala Capital Management fully exited LYRA THERAPEUTICS INC in Q2 2024, selling an estimated $17.5M.
  • Nantahala Capital Management's ten largest holdings make up 58% of its $1.71B portfolio in Q2 2024.
  • Nantahala Capital Management opened 23 new positions and closed 16 in Q2 2024.
  • Nantahala Capital Management's portfolio value fell 2.3% quarter-over-quarter to $1.71B.

Based on Nantahala Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.